+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human Reproductive Technologies Market - Global Forecast 2026-2032- Product Image
Human Reproductive Technologies Market - Global Forecast 2026-2032- Product Image
Sale

Human Reproductive Technologies Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5887220
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Human Reproductive Technologies Market is projected to reach USD 34.53 Billion in 2026. It is expected to continue growing at a CAGR of 6.61%, reaching USD 50.81 Billion by 2032.

Human Reproductive Technologies: Executive Summary

Human reproductive technologies encompass clinical, laboratory, diagnostic, and preservation approaches used to support conception, fertility management, and reproductive planning. The field is shaped by demographic change, delayed parenthood, infertility care needs, genetic insights, evolving regulation, and growing demand for individualized treatment pathways. Access, affordability, clinical quality, and ethical governance remain central considerations across health systems.

Clinical Integration and Regulatory Change Are Reshaping Reproductive Care

The landscape is moving from isolated fertility procedures toward integrated care pathways that connect diagnosis, treatment, laboratory services, genetic assessment, cryopreservation, and long-term follow-up. Advances in laboratory protocols and reproductive medicine are being accompanied by closer scrutiny of consent, embryo handling, donor governance, data protection, and equitable access. Regulation differs substantially by jurisdiction, making compliance capability and transparent patient communication essential.

Artificial Intelligence Is Strengthening Decision Support and Laboratory Workflows

Artificial intelligence is being applied to image interpretation, embryo assessment, clinical risk stratification, appointment coordination, documentation, and operational quality control. Its practical value depends on representative training data, independent validation, explainability, cybersecurity, and clinician oversight. Leaders should treat AI as decision support rather than a substitute for professional judgment, and should establish governance for bias monitoring, informed consent, model performance, and responsibility for errors.

Regional Conditions Create Uneven Access and Adoption Patterns

North America combines advanced clinical infrastructure with strong demand for personalized fertility care, while affordability and insurance coverage remain important access constraints. Latin America is characterized by expanding private-sector capacity alongside differences in regulation, public provision, and treatment affordability. Europe benefits from established medical systems and research capabilities, but national rules on treatment eligibility, donor conception, embryo use, and reimbursement vary. The Middle East reflects differing legal, cultural, and religious frameworks that influence permissible services and patient pathways. Africa faces substantial unmet need, uneven specialist capacity, and infrastructure constraints, with opportunities to strengthen training, referral networks, and laboratory standards. Asia-Pacific presents diverse conditions, ranging from highly developed reproductive medicine systems to rapidly expanding services where regulation, affordability, and quality assurance are still evolving.

Multilateral Groups Need Coordinated Standards and Inclusive Access

ASEAN members face differing regulatory maturity and healthcare capacity, creating a need for cross-border quality principles and clinician training. BRICS economies span major differences in public financing, specialist availability, and legal frameworks, making locally appropriate access strategies important. The European Union benefits from shared data and research principles, although implementation of reproductive rules remains nationally differentiated. G7 members generally possess strong research and clinical infrastructure but continue to address affordability, aging populations, and equitable access. GCC states are developing sophisticated healthcare capabilities while navigating distinct ethical and legal requirements. NATO members may benefit from coordinated preparedness, workforce mobility, and health-data safeguards, although reproductive care remains primarily governed through national systems.

Country-Level Priorities Reflect Distinct Regulation, Capacity, and Demographics

Australia emphasizes regulated clinical practice, quality assurance, and access across dispersed populations. Brazil combines substantial clinical expertise with regional disparities and evolving legal interpretation. Canada faces geographic access challenges and differences in provincial coverage. China is balancing demographic priorities, clinical capacity, and detailed governance of assisted reproduction and genetic applications. France, Germany, Italy, and Spain operate within mature European healthcare environments while applying distinct rules on eligibility, reimbursement, donor services, and embryo use. India is expanding clinical capacity amid affordability, quality, and regulatory implementation challenges. Japan and South Korea are responding to low fertility and delayed parenthood while strengthening access and oversight. Mexico is developing services unevenly across regions and requires consistent standards. Russia’s system reflects national regulation and demographic policy priorities. The United Kingdom has established regulatory oversight but continues to debate affordability, access variation, and emerging technologies. The United States has extensive clinical capability, with significant variation in financing, state-level rules, and patient access.

Prioritize Safety, Access, Data Governance, and Workforce Capability

Industry leaders should build integrated care pathways with clear clinical accountability, standardized laboratory quality systems, and transparent outcome reporting. They should assess affordability and geographic access through tiered services, referral partnerships, and appropriate financing models. AI deployments should begin with narrowly defined use cases, prospective validation, human review, and documented performance monitoring. Organizations should also strengthen consent processes, genetic-data protection, cybersecurity, donor and embryo governance, and psychosocial support. Cross-border operations require jurisdiction-specific compliance reviews, while workforce strategies should emphasize embryology, reproductive endocrinology, counseling, bioinformatics, and quality management.

Methodology: Evidence-Based Synthesis of Clinical, Regulatory, and Regional Signals

This executive summary uses a qualitative synthesis framework focused on verified developments in human reproductive technologies. The assessment considers clinical practice, laboratory science, diagnostics, preservation, artificial intelligence, regulation, healthcare access, demographic conditions, and ethical governance. Regional, group, and country observations are organized around documented structural differences rather than market estimates or projections. Findings should be interpreted alongside current laws, professional guidance, peer-reviewed evidence, and locally validated clinical outcomes, because reproductive technology rules and practices change over time.

Responsible Innovation Will Define the Next Phase of Reproductive Technologies

Human reproductive technologies are advancing through the convergence of clinical medicine, laboratory science, genetics, data systems, and AI. Sustainable progress will depend less on technological capability alone than on safety, evidence quality, affordability, ethical legitimacy, and consistent oversight. Organizations that combine innovation with transparent governance, inclusive access, and strong clinical standards will be better positioned to respond to changing reproductive needs across diverse populations.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Human Reproductive Technologies Market, by Technology Type
7.1. Introduction
7.2. Gamete Intrafallopian Transfer
7.3. In Vitro Fertilization
7.3.1. Fresh Embryo Transfer
7.3.2. Frozen Embryo Transfer
7.4. Intracytoplasmic Sperm Injection
7.5. Intrauterine Insemination
7.6. Zygote Intrafallopian Transfer
7.7. Third-Party Reproduction
7.7.1. Donor Oocytes
7.7.2. Donor Sperm
7.7.3. Gestational Carrier
8. Human Reproductive Technologies Market, by Fertility Drug Type
8.1. Introduction
8.2. GnRH Analogue
8.3. Gonadotropin
8.4. Human Chorionic Gonadotropin
8.5. Progesterone
9. Human Reproductive Technologies Market, by Age Group
9.1. Introduction
9.2. Below 25 Years
9.3. Between 25 To 40 Years
9.4. Above 40 Years
10. Human Reproductive Technologies Market, by Application
10.1. Introduction
10.2. Fertility Preservation
10.2.1. Embryo Cryopreservation
10.2.2. Oocyte Cryopreservation
10.2.3. Sperm Cryopreservation
10.3. Genetic Testing
10.3.1. PGT A
10.3.2. PGT M
10.3.3. PGT SR
10.4. Infertility Treatment
10.5. Contraception
11. Human Reproductive Technologies Market, by End User
11.1. Introduction
11.2. Hospitals
11.3. Fertility Clinics
11.4. Cryobanks
11.5. Research & Academic Institutes
12. Human Reproductive Technologies Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. Europe
12.4. North America
12.5. Latin America
12.6. Middle East
12.7. Africa
13. Human Reproductive Technologies Market, by Group
13.1. Introduction
13.2. NATO
13.3. G7
13.4. European Union
13.5. BRICS
13.6. ASEAN
13.7. GCC
14. Human Reproductive Technologies Market, by Country
14.1. Introduction
14.2. United States
14.3. China
14.4. Germany
14.5. Japan
14.6. India
14.7. United Kingdom
14.8. France
14.9. Spain
14.10. Australia
14.11. Canada
14.12. South Korea
14.13. Italy
14.14. Russia
14.15. Brazil
14.16. Mexico
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Nexpring Health
16.2. Merck KGaA
16.3. Bayer AG
16.4. The Cooper Companies, Inc.
16.5. Ferring International Center S.A.
16.6. Thermo Fisher Scientific Inc
16.7. Organon & Co.
16.8. Gedeon Richter Plc
16.9. Cook Group Incorporated
16.10. Vitrolife Group
16.11. Progyny Inc
16.12. Monash IVF Group
16.13. Cryoport Inc
16.14. Esco Lifesciences Group
16.15. Virtus Health Pty Ltd
16.16. Kitazato Corporation
16.17. Carrot Fertility, Inc.
16.18. Kindbody, Inc.
16.19. Genea Biomedx Pty Ltd
16.20. Overture Life Inc
16.21. INVO Fertility, Inc.
16.22. ReproMed Holdings Ltd
16.23. Cofertility Inc
16.24. FertiPro NV
16.25. Hertility Health Ltd
16.26. Indira IVF Hospitals Private Limited
16.27. IVIRMA Global
16.28. LENUS Pharma GesmbH
16.29. Medicover AB
16.30. Natera Inc
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Human Reproductive Technologies Market, Years Considered for the Study
FIGURE 2. Global Human Reproductive Technologies Market, Research Design
FIGURE 3. Global Human Reproductive Technologies Market, Research Framework
FIGURE 4. Global Human Reproductive Technologies Market, Data Triangulation
FIGURE 5. Global Human Reproductive Technologies Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Human Reproductive Technologies Market Size, by Technology Type, 2025 vs 2032 (%)
FIGURE 7. Global Human Reproductive Technologies Market Size, by Technology Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Human Reproductive Technologies Market Size, by Fertility Drug Type, 2025 vs 2032 (%)
FIGURE 9. Global Human Reproductive Technologies Market Size, by Fertility Drug Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Human Reproductive Technologies Market Size, by Age Group, 2025 vs 2032 (%)
FIGURE 11. Global Human Reproductive Technologies Market Size, by Age Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Human Reproductive Technologies Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Human Reproductive Technologies Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Human Reproductive Technologies Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Human Reproductive Technologies Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Human Reproductive Technologies Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Human Reproductive Technologies Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Human Reproductive Technologies Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Human Reproductive Technologies Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Human Reproductive Technologies Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Human Reproductive Technologies Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Human Reproductive Technologies Market Segmentation & Coverage
TABLE 2. Global Human Reproductive Technologies Market Size, 2017-2032 (USD Million)
TABLE 3. Global Human Reproductive Technologies Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 4. Global Gamete Intrafallopian Transfer Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Gamete Intrafallopian Transfer Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Gamete Intrafallopian Transfer Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global In Vitro Fertilization Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global In Vitro Fertilization Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global In Vitro Fertilization Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Fresh Embryo Transfer Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Fresh Embryo Transfer Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Fresh Embryo Transfer Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Frozen Embryo Transfer Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Frozen Embryo Transfer Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Frozen Embryo Transfer Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Intracytoplasmic Sperm Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Intracytoplasmic Sperm Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Intracytoplasmic Sperm Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Intrauterine Insemination Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Intrauterine Insemination Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Intrauterine Insemination Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Zygote Intrafallopian Transfer Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Zygote Intrafallopian Transfer Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Zygote Intrafallopian Transfer Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Third-Party Reproduction Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Third-Party Reproduction Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Third-Party Reproduction Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Donor Oocytes Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Donor Oocytes Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Donor Oocytes Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Donor Sperm Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Donor Sperm Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Donor Sperm Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Gestational Carrier Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Gestational Carrier Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Gestational Carrier Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Human Reproductive Technologies Market Size, by Fertility Drug Type, 2017-2032 (USD Million)
TABLE 38. Global GnRH Analogue Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global GnRH Analogue Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global GnRH Analogue Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Gonadotropin Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Gonadotropin Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Gonadotropin Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Human Chorionic Gonadotropin Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Human Chorionic Gonadotropin Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Human Chorionic Gonadotropin Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Progesterone Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Progesterone Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Progesterone Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Human Reproductive Technologies Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 51. Global Below 25 Years Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Below 25 Years Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Below 25 Years Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Between 25 To 40 Years Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Between 25 To 40 Years Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Between 25 To 40 Years Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Above 40 Years Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Above 40 Years Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Above 40 Years Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Human Reproductive Technologies Market Size, by Application, 2017-2032 (USD Million)
TABLE 61. Global Fertility Preservation Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Fertility Preservation Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Fertility Preservation Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Embryo Cryopreservation Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Embryo Cryopreservation Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Embryo Cryopreservation Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Oocyte Cryopreservation Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Oocyte Cryopreservation Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Oocyte Cryopreservation Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Sperm Cryopreservation Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Sperm Cryopreservation Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Sperm Cryopreservation Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Genetic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Genetic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Genetic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global PGT A Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global PGT A Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global PGT A Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global PGT M Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global PGT M Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global PGT M Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global PGT SR Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global PGT SR Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global PGT SR Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Infertility Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Infertility Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Infertility Treatment Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Contraception Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Contraception Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Contraception Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Human Reproductive Technologies Market Size, by End User, 2017-2032 (USD Million)
TABLE 92. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Fertility Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Fertility Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Fertility Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Cryobanks Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Cryobanks Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Cryobanks Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Research & Academic Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Research & Academic Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Research & Academic Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Human Reproductive Technologies Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Human Reproductive Technologies Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific Human Reproductive Technologies Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific Human Reproductive Technologies Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific Human Reproductive Technologies Market Size, by Third-Party Reproduction, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific Human Reproductive Technologies Market Size, by Fertility Drug Type, 2017-2032 (USD Million)
TABLE 110. Asia-Pacific Human Reproductive Technologies Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific Human Reproductive Technologies Market Size, by Application, 2017-2032 (USD Million)
TABLE 112. Asia-Pacific Human Reproductive Technologies Market Size, by Fertility Preservation, 2017-2032 (USD Million)
TABLE 113. Asia-Pacific Human Reproductive Technologies Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific Human Reproductive Technologies Market Size, by End User, 2017-2032 (USD Million)
TABLE 115. Europe Human Reproductive Technologies Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Europe Human Reproductive Technologies Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 117. Europe Human Reproductive Technologies Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 118. Europe Human Reproductive Technologies Market Size, by Third-Party Reproduction, 2017-2032 (USD Million)
TABLE 119. Europe Human Reproductive Technologies Market Size, by Fertility Drug Type, 2017-2032 (USD Million)
TABLE 120. Europe Human Reproductive Technologies Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 121. Europe Human Reproductive Technologies Market Size, by Application, 2017-2032 (USD Million)
TABLE 122. Europe Human Reproductive Technologies Market Size, by Fertility Preservation, 2017-2032 (USD Million)
TABLE 123. Europe Human Reproductive Technologies Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 124. Europe Human Reproductive Technologies Market Size, by End User, 2017-2032 (USD Million)
TABLE 125. North America Human Reproductive Technologies Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. North America Human Reproductive Technologies Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 127. North America Human Reproductive Technologies Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 128. North America Human Reproductive Technologies Market Size, by Third-Party Reproduction, 2017-2032 (USD Million)
TABLE 129. North America Human Reproductive Technologies Market Size, by Fertility Drug Type, 2017-2032 (USD Million)
TABLE 130. North America Human Reproductive Technologies Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 131. North America Human Reproductive Technologies Market Size, by Application, 2017-2032 (USD Million)
TABLE 132. North America Human Reproductive Technologies Market Size, by Fertility Preservation, 2017-2032 (USD Million)
TABLE 133. North America Human Reproductive Technologies Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 134. North America Human Reproductive Technologies Market Size, by End User, 2017-2032 (USD Million)
TABLE 135. Latin America Human Reproductive Technologies Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Latin America Human Reproductive Technologies Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 137. Latin America Human Reproductive Technologies Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 138. Latin America Human Reproductive Technologies Market Size, by Third-Party Reproduction, 2017-2032 (USD Million)
TABLE 139. Latin America Human Reproductive Technologies Market Size, by Fertility Drug Type, 2017-2032 (USD Million)
TABLE 140. Latin America Human Reproductive Technologies Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 141. Latin America Human Reproductive Technologies Market Size, by Application, 2017-2032 (USD Million)
TABLE 142. Latin America Human Reproductive Technologies Market Size, by Fertility Preservation, 2017-2032 (USD Million)
TABLE 143. Latin America Human Reproductive Technologies Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 144. Latin America Human Reproductive Technologies Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. Middle East Human Reproductive Technologies Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Middle East Human Reproductive Technologies Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 147. Middle East Human Reproductive Technologies Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 148. Middle East Human Reproductive Technologies Market Size, by Third-Party Reproduction, 2017-2032 (USD Million)
TABLE 149. Middle East Human Reproductive Technologies Market Size, by Fertility Drug Type, 2017-2032 (USD Million)
TABLE 150. Middle East Human Reproductive Technologies Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 151. Middle East Human Reproductive Technologies Market Size, by Application, 2017-2032 (USD Million)
TABLE 152. Middle East Human Reproductive Technologies Market Size, by Fertility Preservation, 2017-2032 (USD Million)
TABLE 153. Middle East Human Reproductive Technologies Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 154. Middle East Human Reproductive Technologies Market Size, by End User, 2017-2032 (USD Million)
TABLE 155. Africa Human Reproductive Technologies Market Size, by Region, 2017-2032 (USD Million)
TABLE 156. Africa Human Reproductive Technologies Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 157. Africa Human Reproductive Technologies Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 158. Africa Human Reproductive Technologies Market Size, by Third-Party Reproduction, 2017-2032 (USD Million)
TABLE 159. Africa Human Reproductive Technologies Market Size, by Fertility Drug Type, 2017-2032 (USD Million)
TABLE 160. Africa Human Reproductive Technologies Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 161. Africa Human Reproductive Technologies Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. Africa Human Reproductive Technologies Market Size, by Fertility Preservation, 2017-2032 (USD Million)
TABLE 163. Africa Human Reproductive Technologies Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 164. Africa Human Reproductive Technologies Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. Global Human Reproductive Technologies Market Size, by Group, 2017-2032 (USD Million)
TABLE 166. NATO Human Reproductive Technologies Market Size, by Group, 2017-2032 (USD Million)
TABLE 167. NATO Human Reproductive Technologies Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 168. NATO Human Reproductive Technologies Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 169. NATO Human Reproductive Technologies Market Size, by Third-Party Reproduction, 2017-2032 (USD Million)
TABLE 170. NATO Human Reproductive Technologies Market Size, by Fertility Drug Type, 2017-2032 (USD Million)
TABLE 171. NATO Human Reproductive Technologies Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 172. NATO Human Reproductive Technologies Market Size, by Application, 2017-2032 (USD Million)
TABLE 173. NATO Human Reproductive Technologies Market Size, by Fertility Preservation, 2017-2032 (USD Million)
TABLE 174. NATO Human Reproductive Technologies Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 175. NATO Human Reproductive Technologies Market Size, by End User, 2017-2032 (USD Million)
TABLE 176. G7 Human Reproductive Technologies Market Size, by Group, 2017-2032 (USD Million)
TABLE 177. G7 Human Reproductive Technologies Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 178. G7 Human Reproductive Technologies Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 179. G7 Human Reproductive Technologies Market Size, by Third-Party Reproduction, 2017-2032 (USD Million)
TABLE 180. G7 Human Reproductive Technologies Market Size, by Fertility Drug Type, 2017-2032 (USD Million)
TABLE 181. G7 Human Reproductive Technologies Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 182. G7 Human Reproductive Technologies Market Size, by Application, 2017-2032 (USD Million)
TABLE 183. G7 Human Reproductive Technologies Market Size, by Fertility Preservation, 2017-2032 (USD Million)
TABLE 184. G7 Human Reproductive Technologies Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 185. G7 Human Reproductive Technologies Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. European Union Human Reproductive Technologies Market Size, by Group, 2017-2032 (USD Million)
TABLE 187. European Union Human Reproductive Technologies Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 188. European Union Human Reproductive Technologies Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 189. European Union Human Reproductive Technologies Market Size, by Third-Party Reproduction, 2017-2032 (USD Million)
TABLE 190. European Union Human Reproductive Technologies Market Size, by Fertility Drug Type, 2017-2032 (USD Million)
TABLE 191. European Union Human Reproductive Technologies Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 192. European Union Human Reproductive Technologies Market Size, by Application, 2017-2032 (USD Million)
TABLE 193. European Union Human Reproductive Technologies Market Size, by Fertility Preservation, 2017-2032 (USD Million)
TABLE 194. European Union Human Reproductive Technologies Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 195. European Union Human Reproductive Technologies Market Size, by End User, 2017-2032 (USD Million)
TABLE 196. BRICS Human Reproductive Technologies Market Size, by Group, 2017-2032 (USD Million)
TABLE 197. BRICS Human Reproductive Technologies Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 198. BRICS Human Reproductive Technologies Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 199. BRICS Human Reproductive Technologies Market Size, by Third-Party Reproduction, 2017-2032 (USD Million)
TABLE 200. BRICS Human Reproductive Technologies Market Size, by Fertility Drug Type, 2017-2032 (USD Million)
TABLE 201. BRICS Human Reproductive Technologies Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 202. BRICS Human Reproductive Technologies Market Size, by Application, 2017-2032 (USD Million)
TABLE 203. BRICS Human Reproductive Technologies Market Size, by Fertility Preservation, 2017-2032 (USD Million)
TABLE 204. BRICS Human Reproductive Technologies Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 205. BRICS Human Reproductive Technologies Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. ASEAN Human Reproductive Technologies Market Size, by Group, 2017-2032 (USD Million)
TABLE 207. ASEAN Human Reproductive Technologies Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 208. ASEAN Human Reproductive Technologies Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 209. ASEAN Human Reproductive Technologies Market Size, by Third-Party Reproduction, 2017-2032 (USD Million)
TABLE 210. ASEAN Human Reproductive Technologies Market Size, by Fertility Drug Type, 2017-2032 (USD Million)
TABLE 211. ASEAN Human Reproductive Technologies Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 212. ASEAN Human Reproductive Technologies Market Size, by Application, 2017-2032 (USD Million)
TABLE 213. ASEAN Human Reproductive Technologies Market Size, by Fertility Preservation, 2017-2032 (USD Million)
TABLE 214. ASEAN Human Reproductive Technologies Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 215. ASEAN Human Reproductive Technologies Market Size, by End User, 2017-2032 (USD Million)
TABLE 216. GCC Human Reproductive Technologies Market Size, by Group, 2017-2032 (USD Million)
TABLE 217. GCC Human Reproductive Technologies Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 218. GCC Human Reproductive Technologies Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 219. GCC Human Reproductive Technologies Market Size, by Third-Party Reproduction, 2017-2032 (USD Million)
TABLE 220. GCC Human Reproductive Technologies Market Size, by Fertility Drug Type, 2017-2032 (USD Million)
TABLE 221. GCC Human Reproductive Technologies Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 222. GCC Human Reproductive Technologies Market Size, by Application, 2017-2032 (USD Million)
TABLE 223. GCC Human Reproductive Technologies Market Size, by Fertility Preservation, 2017-2032 (USD Million)
TABLE 224. GCC Human Reproductive Technologies Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 225. GCC Human Reproductive Technologies Market Size, by End User, 2017-2032 (USD Million)
TABLE 226. Global Human Reproductive Technologies Market Size, by Country, 2017-2032 (USD Million)
TABLE 227. United States Human Reproductive Technologies Market Size, 2017-2032 (USD Million)
TABLE 228. United States Human Reproductive Technologies Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 229. United States Human Reproductive Technologies Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 230. United States Human Reproductive Technologies Market Size, by Third-Party Reproduction, 2017-2032 (USD Million)
TABLE 231. United States Human Reproductive Technologies Market Size, by Fertility Drug Type, 2017-2032 (USD Million)
TABLE 232. United States Human Reproductive Technologies Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 233. United States Human Reproductive Technologies Market Size, by Application, 2017-2032 (USD Million)
TABLE 234. United States Human Reproductive Technologies Market Size, by Fertility Preservation, 2017-2032 (USD Million)
TABLE 235. United States Human Reproductive Technologies Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 236. United States Human Reproductive Technologies Market Size, by End User, 2017-2032 (USD Million)
TABLE 237. China Human Reproductive Technologies Market Size, 2017-2032 (USD Million)
TABLE 238. China Human Reproductive Technologies Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 239. China Human Reproductive Technologies Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 240. China Human Reproductive Technologies Market Size, by Third-Party Reproduction, 2017-2032 (USD Million)
TABLE 241. China Human Reproductive Technologies Market Size, by Fertility Drug Type, 2017-2032 (USD Million)
TABLE 242. China Human Reproductive Technologies Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 243. China Human Reproductive Technologies Market Size, by Application, 2017-2032 (USD Million)
TABLE 244. China Human Reproductive Technologies Market Size, by Fertility Preservation, 2017-2032 (USD Million)
TABLE 245. China Human Reproductive Technologies Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 246. China Human Reproductive Technologies Market Size, by End User, 2017-2032 (USD Million)
TABLE 247. Germany Human Reproductive Technologies Market Size, 2017-2032 (USD Million)
TABLE 248. Germany Human Reproductive Technologies Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 249. Germany Human Reproductive Technologies Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 250. Germany Human Reproductive Technologies Market Size, by Third-Party Reproduction, 2017-2032 (USD Million)
TABLE 251. Germany Human Reproductive Technologies Market Size, by Fertility Drug Type, 2017-2032 (USD Million)
TABLE 252. Germany Human Reproductive Technologies Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 253. Germany Human Reproductive Technologies Market Size, by Application, 2017-2032 (USD Million)
TABLE 254. Germany Human Reproductive Technologies Market Size, by Fertility Preservation, 2017-2032 (USD Million)
TABLE 255. Germany Human Reproductive Technologies Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 256. Germany Human Reproductive Technologies Market Size, by End User, 2017-2032 (USD Million)
TABLE 257. Japan Human Reproductive Technologies Market Size, 2017-2032 (USD Million)
TABLE 258. Japan Human Reproductive Technologies Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 259. Japan Human Reproductive Technologies Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 260. Japan Human Reproductive Technologies Market Size, by Third-Party Reproduction, 2017-2032 (USD Million)
TABLE 261. Japan Human Reproductive Technologies Market Size, by Fertility Drug Type, 2017-2032 (USD Million)
TABLE 262. Japan Human Reproductive Technologies Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 263. Japan Human Reproductive Technologies Market Size, by Application, 2017-2032 (USD Million)
TABLE 264. Japan Human Reproductive Technologies Market Size, by Fertility Preservation, 2017-2032 (USD Million)
TABLE 265. Japan Human Reproductive Technologies Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 266. Japan Human Reproductive Technologies Market Size, by End User, 2017-2032 (USD Million)
TABLE 267. India Human Reproductive Technologies Market Size, 2017-2032 (USD Million)
TABLE 268. India Human Reproductive Technologies Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 269. India Human Reproductive Technologies Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 270. India Human Reproductive Technologies Market Size, by Third-Party Reproduction, 2017-2032 (USD Million)
TABLE 271. India Human Reproductive Technologies Market Size, by Fertility Drug Type, 2017-2032 (USD Million)
TABLE 272. India Human Reproductive Technologies Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 273. India Human Reproductive Technologies Market Size, by Application, 2017-2032 (USD Million)
TABLE 274. India Human Reproductive Technologies Market Size, by Fertility Preservation, 2017-2032 (USD Million)
TABLE 275. India Human Reproductive Technologies Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 276. India Human Reproductive Technologies Market Size, by End User, 2017-2032 (USD Million)
TABLE 277. United Kingdom Human Reproductive Technologies Market Size, 2017-2032 (USD Million)
TABLE 278. United Kingdom Human Reproductive Technologies Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 279. United Kingdom Human Reproductive Technologies Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 280. United Kingdom Human Reproductive Technologies Market Size, by Third-Party Reproduction, 2017-2032 (USD Million)
TABLE 281. United Kingdom Human Reproductive Technologies Market Size, by Fertility Drug Type, 2017-2032 (USD Million)
TABLE 282. United Kingdom Human Reproductive Technologies Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 283. United Kingdom Human Reproductive Technologies Market Size, by Application, 2017-2032 (USD Million)
TABLE 284. United Kingdom Human Reproductive Technologies Market Size, by Fertility Preservation, 2017-2032 (USD Million)
TABLE 285. United Kingdom Human Reproductive Technologies Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 286. United Kingdom Human Reproductive Technologies Market Size, by End User, 2017-2032 (USD Million)
TABLE 287. France Human Reproductive Technologies Market Size, 2017-2032 (USD Million)
TABLE 288. France Human Reproductive Technologies Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 289. France Human Reproductive Technologies Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 290. France Human Reproductive Technologies Market Size, by Third-Party Reproduction, 2017-2032 (USD Million)
TABLE 291. France Human Reproductive Technologies Market Size, by Fertility Drug Type, 2017-2032 (USD Million)
TABLE 292. France Human Reproductive Technologies Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 293. France Human Reproductive Technologies Market Size, by Application, 2017-2032 (USD Million)
TABLE 294. France Human Reproductive Technologies Market Size, by Fertility Preservation, 2017-2032 (USD Million)
TABLE 295. France Human Reproductive Technologies Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 296. France Human Reproductive Technologies Market Size, by End User, 2017-2032 (USD Million)
TABLE 297. Spain Human Reproductive Technologies Market Size, 2017-2032 (USD Million)
TABLE 298. Spain Human Reproductive Technologies Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 299. Spain Human Reproductive Technologies Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 300. Spain Human Reproductive Technologies Market Size, by Third-Party Reproduction, 2017-2032 (USD Million)
TABLE 301. Spain Human Reproductive Technologies Market Size, by Fertility Drug Type, 2017-2032 (USD Million)
TABLE 302. Spain Human Reproductive Technologies Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 303. Spain Human Reproductive Technologies Market Size, by Application, 2017-2032 (USD Million)
TABLE 304. Spain Human Reproductive Technologies Market Size, by Fertility Preservation, 2017-2032 (USD Million)
TABLE 305. Spain Human Reproductive Technologies Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 306. Spain Human Reproductive Technologies Market Size, by End User, 2017-2032 (USD Million)
TABLE 307. Australia Human Reproductive Technologies Market Size, 2017-2032 (USD Million)
TABLE 308. Australia Human Reproductive Technologies Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 309. Australia Human Reproductive Technologies Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 310. Australia Human Reproductive Technologies Market Size, by Third-Party Reproduction, 2017-2032 (USD Million)
TABLE 311. Australia Human Reproductive Technologies Market Size, by Fertility Drug Type, 2017-2032 (USD Million)
TABLE 312. Australia Human Reproductive Technologies Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 313. Australia Human Reproductive Technologies Market Size, by Application, 2017-2032 (USD Million)
TABLE 314. Australia Human Reproductive Technologies Market Size, by Fertility Preservation, 2017-2032 (USD Million)
TABLE 315. Australia Human Reproductive Technologies Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 316. Australia Human Reproductive Technologies Market Size, by End User, 2017-2032 (USD Million)
TABLE 317. Canada Human Reproductive Technologies Market Size, 2017-2032 (USD Million)
TABLE 318. Canada Human Reproductive Technologies Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 319. Canada Human Reproductive Technologies Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 320. Canada Human Reproductive Technologies Market Size, by Third-Party Reproduction, 2017-2032 (USD Million)
TABLE 321. Canada Human Reproductive Technologies Market Size, by Fertility Drug Type, 2017-2032 (USD Million)
TABLE 322. Canada Human Reproductive Technologies Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 323. Canada Human Reproductive Technologies Market Size, by Application, 2017-2032 (USD Million)
TABLE 324. Canada Human Reproductive Technologies Market Size, by Fertility Preservation, 2017-2032 (USD Million)
TABLE 325. Canada Human Reproductive Technologies Market Size, by Genetic Testing, 2017-2032 (US

Companies Mentioned

  • Nexpring Health
  • Merck KGaA
  • Bayer AG
  • The Cooper Companies, Inc.
  • Ferring International Center S.A.
  • Thermo Fisher Scientific Inc
  • Organon & Co.
  • Gedeon Richter Plc
  • Cook Group Incorporated
  • Vitrolife Group
  • Progyny Inc
  • Monash IVF Group
  • Cryoport Inc
  • Esco Lifesciences Group
  • Virtus Health Pty Ltd
  • Kitazato Corporation
  • Carrot Fertility, Inc.
  • Kindbody, Inc.
  • Genea Biomedx Pty Ltd
  • Overture Life Inc
  • INVO Fertility, Inc.
  • ReproMed Holdings Ltd
  • Cofertility Inc
  • FertiPro NV
  • Hertility Health Ltd
  • Indira IVF Hospitals Private Limited
  • IVIRMA Global
  • LENUS Pharma GesmbH
  • Medicover AB
  • Natera Inc

Related Topics

Related Reports

In-Vitro Fertilization Market - Global Forecast 2026-2032 - Product Image

In-Vitro Fertilization Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Assisted Reproductive Technology Market (ART) - Global Forecast 2026-2032 - Product Image

Assisted Reproductive Technology Market (ART) - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Human Reproductive Technologies - Global Strategic Business Report - Product Image

Human Reproductive Technologies - Global Strategic Business Report

  • Report
  • 339 Pages
  • Global
From
Assisted Reproductive Technology Market Report by Type, End Users, Country and Company Analysis 2026-2034 - Product Image

Assisted Reproductive Technology Market Report by Type, End Users, Country and Company Analysis 2026-2034

  • Report
  • 200 Pages
  • Global
From
Fertility Services - Global Strategic Business Report - Product Image

Fertility Services - Global Strategic Business Report

  • Report
  • 392 Pages
  • Global
From

About the Human Reproductive Technologies Market

The Human Reproductive Technologies market is a subset of the Sexual and Reproductive Health Drugs market. It includes products and services related to fertility, contraception, and assisted reproductive technologies. These technologies are used to help individuals and couples conceive, prevent pregnancy, and manage reproductive health. They include fertility treatments such as in vitro fertilization (IVF), intrauterine insemination (IUI), and ovulation induction, as well as contraception methods such as birth control pills, intrauterine devices (IUDs), and male and female condoms. Assisted reproductive technologies include egg and sperm donation, surrogacy, and preimplantation genetic diagnosis (PGD). Some companies in the Human Reproductive Technologies market include Ferring Pharmaceuticals, Merck, Bayer, and CooperSurgical. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.